161 related articles for article (PubMed ID: 14463342)
1. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
[No Abstract] [Full Text] [Related]
2. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
[No Abstract] [Full Text] [Related]
3. Effects of LSD 25 and JB 318 on tests of visual and perceptual functions in man.
OSTFELD AM
Fed Proc; 1961 Dec; 20():876-84. PubMed ID: 14482599
[No Abstract] [Full Text] [Related]
4. Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study.
LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
Arch Gen Psychiatry; 1960 Aug; 3():176-87. PubMed ID: 14415047
[No Abstract] [Full Text] [Related]
5. Comparison of psilocin with psilocybin, mescaline and LSD-25.
WOLBACH AB; MINER EJ; ISBELL H
Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
[No Abstract] [Full Text] [Related]
6. Comparison of the reactions induced by psilocybin and LSD-25 in man.
ISBELL H
Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
[No Abstract] [Full Text] [Related]
7. Cross tolerance between LSD and psilocybin.
ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
[No Abstract] [Full Text] [Related]
8. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
HOLFELD H
Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
[No Abstract] [Full Text] [Related]
9. Effect of lysergic acid diethylamide and bufotenine on performance of trained rats.
MAHLER DJ; HUMOLLER FL
Proc Soc Exp Biol Med; 1959; 102():697-701. PubMed ID: 14419947
[No Abstract] [Full Text] [Related]
10. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
GERSHON S; OLARIU J
J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
[No Abstract] [Full Text] [Related]
11. [Modern treatments in psychiatry. Hallucinogens: psychosis induced by LSD].
JOST F; GEERTZ VW
Folia Clin Int (Barc); 1961 Sep; 11():440-5 contd. PubMed ID: 14452572
[No Abstract] [Full Text] [Related]
12. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
Westkaemper RB; Glennon RA
NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
[No Abstract] [Full Text] [Related]
13. Clinical observations of simultaneous hallucinogen administration in identical twins.
WILKENS B; MALITZ S; ESECOVER H
Am J Psychiatry; 1962 Mar; 118():815-8. PubMed ID: 14007020
[No Abstract] [Full Text] [Related]
14. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
Votava Z; Podvalová I; Vojtĕchovský M
Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
[No Abstract] [Full Text] [Related]
15. A comparison of 2,3-dihydro-lysergic acid diethylamide with LSD-25.
Gorodetzky CW; Isbell H
Psychopharmacologia; 1964 Sep; 6(3):229-33. PubMed ID: 5319153
[No Abstract] [Full Text] [Related]
16. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
[TBL] [Abstract][Full Text] [Related]
17. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
18. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
Winter JC
J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
[No Abstract] [Full Text] [Related]
19. A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects.
Liester MB
Curr Drug Abuse Rev; 2014; 7(3):146-56. PubMed ID: 25563445
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of lysergic acid diethylamide: case reports and review of the treatment of intoxication.
Blaho K; Merigian K; Winbery S; Geraci SA; Smartt C
Am J Ther; 1997; 4(5-6):211-21. PubMed ID: 10423613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
